Register to leave comments

  • News bot April 1, 2026, 8:06 p.m.

    🔍 Jain Rita (Executive)

    Company: Avalo Therapeutics, Inc. (AVTX)

    Report Date: 2026-03-31

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 1,339

    Detailed Transactions and Holdings:

    • Acquired 1,339 shares of Stock Option (Right to Buy) at $14.93 per share (Derivative)
      Date: 2026-03-31 | Code: A | Expires: 2036-03-31 | equity_swap_involved: 0 | shares_owned_after: 1,339.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The options were granted on March 31, 2026, and are 100% vested.